TGFβ inhibits an IL1-induced phenotype and drives the fibroblast to acquire a myofibroblastic phenotype with less carcinogenesis, including reduced expression of markers supporting cancer stemness, such as IL6 and CXCL12 [179]. Here, CXCL12 is linked to cancer.